Envision Scientific
Developer and manufacturer of advanced vascular drug-delivery devices and associated manufacturing systems. Offers end-to-end capabilities spanning development and production of drug-eluting stents and drug-coated balloons, laboratory-based analytical testing, integrated quality systems with 21 CFR Part 11 data controls, and engineering services for machinery design and system integration. Operates ISO-certified facilities with controlled environments and supplies products to a global customer base.
Industries
Nr. of Employees
small (1-50)
Envision Scientific
Patents
Biodegradable medical devices and method to control degradation of the biodegradable medical devices
US-9526812-B2
View DetailsRe-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano-encapsulated drug in human artery with body ph
US-9259518-B2
View DetailsRe-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano-encapsulated drug in human artery with body ph
US-8778013-B2
View Details
Biodegradable medical devices and method to control degradation of the biodegradable medical devices
US-9526812-B2
View DetailsRe-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano-encapsulated drug in human artery with body ph
US-9259518-B2
View DetailsRe-establishment of blood flow in blocked human arteries by transferring nano-encapsulated drug through medical devices, designed for the same and releasing the nano-encapsulated drug in human artery with body ph
US-8778013-B2
View DetailsProducts
Drug-eluting stent (DES) systems
Stent systems engineered to deliver controlled local release of therapeutic agents to vascular tissues; includes variants with polymer, biodegradable polymer, and polymer-free coating approaches.
Drug-coated balloons (DCB)
Balloon catheters with drug coatings for topical delivery of therapeutic agents to vascular tissue during angioplasty procedures; includes sub-micron/nano-coating approaches for improved transfer.
MagicTouch PTA
Sirolimus Coated Balloon for the treatment of below-the-knee and femoropopliteal arterial disease.
MagicTouch SCB
World’s first Sirolimus Coated Balloon for targeted sub-micron drug delivery across the CAD spectrum.
Nostrum
Sirolimus-Eluting Stent with abluminal biodegradable coating, designed for precise drug delivery and enhanced vessel healing.
Mitigator
Sirolimus-Eluting Stent with a biodegradable polymer that degrades in 6–7 months, offering optimal flexibility and faster healing.
Drug-eluting stent (DES) systems
Stent systems engineered to deliver controlled local release of therapeutic agents to vascular tissues; includes variants with polymer, biodegradable polymer, and polymer-free coating approaches.
Drug-coated balloons (DCB)
Balloon catheters with drug coatings for topical delivery of therapeutic agents to vascular tissue during angioplasty procedures; includes sub-micron/nano-coating approaches for improved transfer.
MagicTouch PTA
Sirolimus Coated Balloon for the treatment of below-the-knee and femoropopliteal arterial disease.
MagicTouch SCB
World’s first Sirolimus Coated Balloon for targeted sub-micron drug delivery across the CAD spectrum.
Nostrum
Sirolimus-Eluting Stent with abluminal biodegradable coating, designed for precise drug delivery and enhanced vessel healing.
Mitigator
Sirolimus-Eluting Stent with a biodegradable polymer that degrades in 6–7 months, offering optimal flexibility and faster healing.
Services
End-to-end manufacturing services for drug-eluting stents and drug-coated balloons including coating, assembly and device testing.
Design and integration of custom manufacturing equipment and automated production systems, including robotics and AI-enabled components.
AI-powered analytics services for operational insight, production optimization and real-time monitoring.
End-to-end manufacturing services for drug-eluting stents and drug-coated balloons including coating, assembly and device testing.
Design and integration of custom manufacturing equipment and automated production systems, including robotics and AI-enabled components.
AI-powered analytics services for operational insight, production optimization and real-time monitoring.
Expertise Areas
- Medical device manufacturing (vascular drug-delivery devices)
- Coating technologies for localized drug delivery
- Analytical testing and stability studies
- Quality management systems and regulatory compliance
Key Technologies
- Drug-eluting stent manufacturing
- Drug-coated balloon manufacturing
- Nano/sub-micron coating technologies
- HPLC
News & Updates
Summary of primary results from the SirPAD randomized controlled trial evaluating a sirolimus-coated balloon versus uncoated balloons for peripheral artery disease; results were presented at a clinical meeting and published in the New England Journal of Medicine.
Announcement of first patient enrollment in a U.S. IDE pivotal trial evaluating a sirolimus-coated balloon for below-the-knee arterial disease as part of a PAD clinical program.
Summary of primary results from the SirPAD randomized controlled trial evaluating a sirolimus-coated balloon versus uncoated balloons for peripheral artery disease; results were presented at a clinical meeting and published in the New England Journal of Medicine.
Announcement of first patient enrollment in a U.S. IDE pivotal trial evaluating a sirolimus-coated balloon for below-the-knee arterial disease as part of a PAD clinical program.